Skip to main navigation menu Skip to main content Skip to site footer
Brazilian Journal of Clinical Medicine and Review

Health Review

Vol. 3 No. 1 (2025): January/December - 2025

A Promising Frontier: Cannabis's Medicinal Prospects in Alagoas, Brazil

DOI
https://doi.org/10.52600/2965-0968.bjcmr.2025.3.1.bjcmr24
Submitted
November 30, 2024
Published
2024-12-27

Abstract

In 2022, the state of Alagoas, located in the northeastern region of Brazil, published new legislation regarding the medicinal use of Cannabis, which includes provisions for medical prescription, support for scientific research, continued education for healthcare professionals, and public events on the topic. Therefore, this study aimed to conduct a survey within the state of Alagoas, focusing on local scientific publications, the number of Cannabis-based medications prescribed, the development of clinical research and patents involving Cannabis, and initiatives for public events on the subject. The findings revealed that scientific research remains limited to publications in regional journals, with minimal international reach. Additionally, the number of prescribed and sold medications in Alagoas could not be obtained due to a failure in the national registration system. There is no development of clinical research or patents in Alagoas involving Cannabis. Lastly, there is a significant number of initiatives aimed at informing the non-specialized population and patients about the topic. Thus, our study showed that the local legislation is promising for the therapeutic use of Cannabis, but the state of Alagoas has yet to fully embrace all the possibilities authorized by the law.

References

  1. Zamengo L, Frison G, Zwitser G, Salomone A, Freeman TP. Cannabis knowledge and implications for health: considerations regarding the legalization of non-medical Cannabis. Med Sci Law. 2020 Oct;60(4):309-314. doi: 10.1177/0025802420934255.
  2. Kilmer B, Pérez-Dávila S. Nine insights from 10 years of legal Cannabis for nonmedical purposes. Clin Ther. 2023 Jun;45(6):496-505. doi: 10.1016/j.clinthera.2023.03.005.
  3. Laranjeira R, Martin D. Traps in Cannabis policies in Brazil. Braz J Psychiatry. 2019 Nov-Dec;41(6):475-476. doi: 10.1590/1516-4446-2019-4108.
  4. Scheffer M. Alagoas. In: Demografia médica no Brasil. São Paulo: FMUSP, AMB; 2023. p. 45-47.
  5. Malta RU, Verçosa RCM, Barbosa DFR, Pereira TS, Santana NMP, Silva MB, Santos EG. Compreensão da enfermagem diante do mecanismo da Cannabis em pacientes oncológicos. Braz J Dev. 2021;7(1):8394-8407. doi: 10.34117/bjdv7n1-569.
  6. de Almeida Neto JT, de Almeida Neto JT, Cavalcante ADC, de Almeida LF, Moura TS, Fermoseli AFO. Alterações neurofi-siológicas e cognitivas decorrentes do uso crônico da maconha: uma revisão de literatura. Cad Grad Ciênc Hum Soc Unit Alagoas. 2020;6(1):85. Available from: https://periodicos.set.edu.br/fitshumanas/article/view/8204
  7. Notomi M. Intoxicação por Cannabis sativa: desafios relacionados à clínica de animais de companhia. Pubvet. 2020;14(9). doi: 10.31533/pubvet.v14n9a651.1-97.
  8. Delmiro JA, Torres FBO, Almeida AAC, Ferreira PMP, Santos Júnior AF, Cavalcanti BC, Silva FCC, Magalhães HIF, Ferreira JRO. Food products based on Cannabis extract: from “Brisadeiro” to searching for a therapeutic effect. Res Soc Dev. 2022;11(2):e10711225422. doi: 10.33448/rsd-v11i2.25422.
  9. Lins MP, de Melo IS. Exploring the interplay between cannabinoids and thymic functions. Toxicol Sci. 2024 Nov 1;202(1):1-12. doi: 10.1093/toxsci/kfae114.
  10. Freitas-Santos J, Brito IRR, Santana-Melo I, Oliveira KB, de Souza FMA, Gitai DLG, Duzzioni M, Bueno NB, de Araujo LA, Shetty AK, Castro OW. Effects of cocaine, nicotine, and marijuana exposure in Drosophila melanogaster development: a systematic review and meta-analysis. Prog Neuropsychopharmacol Biol Psychiatry. 2024 Aug 30;134:111049. doi: 10.1016/j.pnpbp.2024.111049.
  11. Silva EVFF, Santos EC, Silva VEF, Aguiar JES, Felismino RJA, Silva JC, Azevedo CP, Pereira RCA, Eliziario JLL, Moura MABF. Therapeutic potential of Cannabis sativa in the treatment of symptoms in autistic children: a literature review. Ciênc Saúde. 2024;28(139):e10202410312134. doi: 10.69849/revistaft/cs10202410312134.
  12. Correia FS, Oliveira REC, Escodro PB. Indicações da Cannabis sativa na terapêutica veterinária – revisão sistemática. Observ Econ Latinoam. 2024;22(12):e8061. doi: 10.55905/oelv22n12-034.
  13. Santos ALF, dos Santos ESRN, Dibai Filho AV, Gomes CAF de P, Pinto C de M, Souza C da S. Efeitos do uso de Cannabis medicinal no tratamento da dor relacionada ao câncer: uma revisão sistemática. Cons Saúde. 2024 Sep 5;23(1):e26196. Available from: https://uninove.emnuvens.com.br/saude/article/view/26196.
  14. de Araújo Filho JD, Sousa DL, de Faria RFS, Siqueira NMR, Gomes RNS, Silva JA, Matsuoka RT. Cannabis medicinal no tra-tamento de dor musculoesquelética: uma overview de estudos de revisão. Contrib Cienc Soc. 2024;17(1):6853-6864. doi: 10.55905/revconv.17n.1-413.
  15. Santos-Júnior PFDS, Martins-Filho PR, Quintans-Júnior LJ, Silva-Júnior EFD. Letter to the Editor: Would cannabidiol be a therapeutic alternative to treat monkeypox symptoms? Cannabis Cannabinoid Res. 2023 Apr;8(2):379-380. doi: 10.1089/can.2022.0261.
  16. Oliveira EHA, Sorgato JPA, Silva RC, Martins PKS, Uchôa SBB, Tonholo J. Mapeamento tecnológico do canabidiol (CBD) para finalidades farmacêuticas no Brasil. Cad Prospec. 2018;11(3):900. doi: 10.9771/cp.v11i3.27098.
  17. Upadhya D, Castro OW, Upadhya R, Shetty AK. Prospects of cannabidiol for easing status epilepticus-induced epileptogenesis and related comorbidities. Mol Neurobiol. 2018;55(8):6956-6964. doi: 10.1007/s12035-018-0898-y.
  18. National Health Surveillance Agency of Brazil. Anvisa alerta sobre instabilidade no sistema SNGPC. 2022. Available from: https://www.gov.br/anvisa/pt-br/assuntos/noticias-anvisa/2021/anvisa-alerta-sobre-instabilidade-no-sistema-sngpc.
  19. Portela R, Mota DM, Ferreira PJG, Lula MD, Reis BB, Oliveira HN, Ruas CM. Judicialization of cannabidiol-based products in Brazil: an analysis from 2019 to 2022. Cad Saude Publica. 2023 Oct 9;39(8):e00024723. doi: 10.1590/0102-311XPT024723.
  20. Pinto CDBS, Esher A, Oliveira CVS, Osório-de-Castro CGS. Expansion of the medical Cannabis market in Brazil and regulatory challenges. Cad Saude Publica. 2024;40(11):e00088624. doi: 10.1590/0102-311XPT088624.
  21. Health State Department of Alagoas. Dados de saúde perfil municipal. 2023. Available from: https://dados.al.gov.br/catalogo/dataset/dados-de-saude-perfil-municipal.
  22. Institute of Cannabinoid Sciences. Quem somos. 2023. Available from: https://www.iccabrasil.com/.